Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.
Ital J Pediatr
; 49(1): 15, 2023 Jan 26.
Article
in English
| MEDLINE | ID: covidwho-2214617
ABSTRACT
Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Gastroenterology
/
COVID-19
/
Liver Diseases
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
Limits:
Child
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Ital J Pediatr
Journal subject:
Pediatrics
Year:
2023
Document Type:
Article
Affiliation country:
S13052-023-01418-7
Similar
MEDLINE
...
LILACS
LIS